ADARx Pharmaceuticals
ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered at 5871 Oberlin Drive, San Diego, California, founded in 2019 and developing next-generation RNA therapeutics intended to control the expression of specific disease drivers with highly selective RNA-targeted medicines. Its proprietary platform spans RNA interference, RNA editing and targeted oligonucleotide delivery, engineered around compact, modular constructs the company says extend reach beyond the liver. The clinical pipeline is led by ADX-324 (onvuzosiran), an siRNA against prekallikrein now in the Phase 3 STOP-HAE study in hereditary angioedema, and ADX-038 (agazisiran), an siRNA against complement factor B in Phase 2 for IgA nephropathy and C3 glomerulopathy, geographic atrophy and paroxysmal nocturnal hemoglobinuria; earlier programmes include ADX-626 (factor XI, thrombosis), ADX-077 (obesity) and ADX-199 (amyloid-beta precursor protein, neurodegeneration), plus undisclosed extrahepatic CNS, immunology and oncology work. The company closed an oversubscribed 200 million dollar Series C in August 2023 co-led by Bain Capital Life Sciences and TCGX, and entered a collaboration and license option agreement with AbbVie in May 2025. ADARx runs no developer program and publishes no product API, no developer portal and no API documentation; the only machine-readable surfaces reachable without credentials are the WordPress REST content APIs behind www.adarx.com and stophae.com, both catalogued here.
ADARx Pharmaceuticals is listed with 2 APIs on the APIs.io network. Tagged areas include Company, Biotechnology, Biopharmaceutical, RNA Therapeutics, and siRNA.
The ADARx Pharmaceuticals catalog on APIs.io includes 1 JSON-LD context and 1 Spectral governance ruleset.
ADARx Pharmaceuticals’ developer surface includes product news, support, authentication, and 31 more developer resources.
What this lets a business do 1
Business capabilities this provider's published APIs can perform, derived from its own contracts. Browse all capabilities →
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Clinical Trial Sponsors (drug pipelines) | standard | 34.5 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
APIs 2
Individual APIs this provider publishes, each with its own machine-readable definition.
ADARx Pharmaceuticals Website (WordPress REST)
The public WordPress REST API (wp-json) of the ADARx Pharmaceuticals website at www.adarx.com: the route index of the site's content management system, catalogued as one site su...
ADARx Pharmaceuticals Website (WordPress REST)
The public WordPress REST API (wp-json) of the ADARx Pharmaceuticals website at stophae.com: the route index of the site's content management system, catalogued as one site surf...
Agent Skills 4
Packaged agent skills for driving this provider's APIs from an AI assistant.
Enumerate the STOP-HAE Phase 3 trial sites
AGENT SKILLHarvest the ADARx media library
AGENT SKILLSemantic Vocabularies 1
JSON-LD contexts and semantic vocabularies used across these APIs.
Spectral Rules 1
Spectral governance rulesets for linting and validating these APIs.
ADARx Pharmaceuticals API Rules
SPECTRALOpenAPI Overlays 2
Overlays applied on top of this provider's contracts. Each card says who wrote it: a document the provider publishes, or one API Evangelist derived or generated.
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 6
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 11
Properties that don't map to a standard resource type
Scroll for all 11
Source (apis.yml)
ADARx Pharmaceuticals API — frequently asked questions
Does ADARx Pharmaceuticals have an API?
Yes. APIs.io lists 2 APIs from ADARx Pharmaceuticals, including ADARx Pharmaceuticals Website (WordPress REST) and ADARx Pharmaceuticals Website (WordPress REST).
How do I authenticate with the ADARx Pharmaceuticals API?
ADARx Pharmaceuticals uses bearer-token authentication (http · 2 schemes). The details are profiled on APIs.io as Adarx Pharmaceuticals Authentication.
Is the ADARx Pharmaceuticals API ready for AI agents?
ADARx Pharmaceuticals has a Kin Score of 20.7 out of 100 (emerging) and an Agent Readiness score of 4.8 (human-only), scored by API Evangelist on 2026-11-06.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.